An overview of psoriatic arthritis including clinical manifestations, assessment, diagnostic criteria, investigations, drug management and GRAPPA guidelines

被引:1
|
作者
Packham, Jonathan [1 ,2 ]
Tarar, Bilal [1 ]
机构
[1] Midlands Partnership NHS Fdn Trust, Haywood Rheumatol Ctr, Stafford, Staffs, England
[2] Univ Nottingham, Acad Unit Populat & Lifespan Sci, Nottingham, England
关键词
assessment; diagnosis; psoriatic arthritis; treatment; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INFLAMMATORY BACK-PAIN; ANKYLOSING-SPONDYLITIS; DISEASE-ACTIVITY; DOUBLE-BLIND; AXIAL SPONDYLOARTHRITIS; AMERICAN-COLLEGE; MULTINATIONAL ASSESSMENT; CLASSIFICATION CRITERIA; EULAR RECOMMENDATIONS;
D O I
10.1002/msc.1693
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psoriatic arthritis (PsA) is a chronic and often progressive inflammatory disease, occurring in up to 30% of patients with psoriasis. Assessment of patients with PsA requires consideration of all disease domains, including peripheral arthritis, axial disease, enthesitis, dactylitis, skin psoriasis, psoriatic nail disease, uveitis and inflammatory bowel disease. Co-morbidities and related conditions should all be considered including: obesity, metabolic syndrome, cardiovascular disease, anxiety/depression, liver disease, chronic infections, malignancy, osteoporosis, fibromyalgia and reproductive health.
引用
收藏
页码:S2 / S11
页数:10
相关论文
共 7 条
  • [1] Clinical assessment in the spondyloarthropathies, including psoriatic arthritis
    Van den Bosch, Filip
    Vander Cryssen, Bert
    Mielants, Herman
    CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (04) : 354 - 358
  • [2] Enthesitis in psoriatic arthritis (Part 3): clinical assessment and management
    Mease, Philip
    RHEUMATOLOGY, 2020, 59 : I21 - I28
  • [3] Psoriatic arthritis treatment to the target: a consensus, evidence-based clinical practice recommendations for the management of psoriatic arthritis and its concomitant clinical manifestations
    El Miedany, Yasser
    El Gaafary, Maha
    GadAllah, Naglaa
    Mansour, Mona
    Fathy, Nihal
    Hassan, Waleed
    Mortada, Mohamed
    Galal, Salwa
    Eissa, Mervat
    Tabra, Samar Abdelhamed
    Foad, Nermeen
    Ali, Rehab
    Medhat, Basma
    El Olemy, Gehan
    Adel, Yasmin
    Ghaleb, Rasha
    Abd El-Latif, Eiman
    Saber, Sally
    Elkaraly, Nourhan
    Abu-Zaid, Mohammed Hassan
    EGYPTIAN RHEUMATOLOGY AND REHABILITATION, 2022, 49 (01)
  • [4] Psoriatic arthritis treatment to the target: a consensus, evidence-based clinical practice recommendations for the management of psoriatic arthritis and its concomitant clinical manifestations
    Yasser El Miedany
    Maha El Gaafary
    Naglaa GadAllah
    Mona Mansour
    Nihal Fathy
    Waleed Hassan
    Mohamed Mortada
    Salwa Galal
    Mervat Eissa
    Samar Abdelhamed Tabra
    Nermeen Foad
    Rehab Ali
    Basma Medhat
    Gehan El Olemy
    Yasmin Adel
    Rasha Ghaleb
    Eiman Abd El-Latif
    Sally Saber
    Nourhan Elkaraly
    Mohammed Hassan Abu-Zaid
    Egyptian Rheumatology and Rehabilitation, 2022, 49
  • [5] Diagnostic criteria for dementia in clinical trials - Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines
    Antuono, P
    Doody, R
    Gilman, S
    Huff, J
    Scheltens, P
    Ueda, K
    Khachaturian, ZS
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1997, 11 : 22 - 25
  • [6] Drug treatment algorithm and recommendations from the 2020 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritis-secondary publication
    Kawahito, Yutaka
    Morinobu, Akio
    Kaneko, Yuko
    Kohno, Masataka
    Hirata, Shintaro
    Kishimoto, Mitsumasa
    Seto, Yohei
    Sugihara, Takahiko
    Tanaka, Eiichi
    Ito, Hiromu
    Kojima, Toshihisa
    Matsushita, Isao
    Nishida, Keiichiro
    Mori, Masaaki
    Murashima, Atsuko
    Yamanaka, Hisashi
    Nakayama, Takeo
    Kojima, Masayo
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2023, 33 (01) : 21 - 35
  • [7] Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis
    Regev, Arie
    Palmer, Melissa
    Avigan, Mark I.
    Dimick-Santos, Lara
    Treem, William R.
    Marcinak, John F.
    Seekins, Daniel
    Krishna, Gopal
    Anania, Frank A.
    Freston, James W.
    Lewis, James H.
    Sanyal, Arun J.
    Chalasani, Naga
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 49 (06) : 702 - 713